Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin as Adjuvant Therapy for Preterm Neonates With Sepsis
NCT06191523Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Apr 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in neonatal sepsis (2 arms), sponsored by Universitas Sebelas Maret. Primary endpoint: Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System at 6 months. Started Apr 2023; status: completed.
02
Drugs
melatonin
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT06191523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06191523.